Welcome to
Sysmex Flow Cytometry Austria!

For ordering please make sure you are in your local shop.
If you are from Austria then please continue.
Otherwise please go to your country.

Go to my country Continue

Article successfully added.

CyFlow™ CD35 FITC

CyFlow™ CD35 FITC
Antigen: CD35
Alternative Name: C3b/C4b-R, CR1
Clone: E11
Application: Flow cytometry
Format/Fluorochrome: FITC
Laser: Blue
Target Species: Human, Non-Human Primates
Field of Interest: Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Emission Maximum: 518 nm
Excitation Maximum: 490 to 495 nm
Isotype: IgG1
Order number: BL832690

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

HLDA Workshop HLDA III—WS Code 204 Quantity 100 tests Volume 0.4 Immunogen Acute... more
CyFlow™ CD35 FITC
HLDA WorkshopHLDA III—WS Code 204
Quantity100 tests
Volume0.4
ImmunogenAcute monocytic leukemia cells and normal blood monocytes
Background InformationCD35 (CR1; complement receptor 1) is a monomeric multiple modular cell surface glycoprotein which serves as receptor for C3b and C4b, the most important components of the complement system leading to clearance of foreign macromolecules. It is expressed mainly on the surface of granulocytes, monocytes, erythrocytes, B cells and folicular dendritic cells. Besides its role in complement cascade, CD35 is involved in blocking BCR-induced proliferation and the differentiation of B cells to plasmablasts and their Ig production.
UsageThe reagent is designed for Flow Cytometry analysis of human blood cells. Recommended usage is 4·µl reagent·/ 100·µl of whole blood or 10^6 cells in a suspension. The content of a vial (0.4 ml) is sufficient for 100 tests.
Storage BufferThe reagent is provided in stabilizing phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Hogg N, Ross GD, Jones DB, Slusarenko M, Walport MJ, Lachmann PJ: Identification of an anti‑monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur·J·Immunol. 1984·Mar; 14(3):236‑43. <·PMID:·6368248·> | McMichael AJ, Beverley PCL, Cobbold S, et al (Eds): Leucocyte Typing III, White Cell Differentiation Antigens. Oxford·University·Press,·Oxford. 1987; 1‑1050. <·NLM·ID:·8913266·> | Nielsen CH, Pedersen ML, Marquart HV, Prodinger WM, Leslie RG: The role of complement receptors type 1 (CR1, CD35 and 2 (CR2, CD21 in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells. Eur·J·Immunol. 2002·May; 32(5):1359‑67. <·PMID:·11981823·> | Kremlitzka M, Polgár A, Fülöp L, Kiss E, Poór G, Erdei A: Complement receptor type 1 (CR1, CD35 is a potent inhibitor of B‑cell functions in rheumatoid arthritis patients. Int·Immunol. 2013·Jan; 25(1):25‑33. <·PMID:·22962438·>